These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33999649)

  • 1. Cannabinoid Profiles in Medical Cannabis Users: Effects of Age, Gender, Symptoms, and Duration of Use.
    Kalaba M; Ware MA
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):840-851. PubMed ID: 33999649
    [No Abstract]   [Full Text] [Related]  

  • 2. Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec.
    Kalaba M; MacNair L; Peters EN; Eglit GML; Rapin L; Hage CE; Prosk E; Ware MA
    Cannabis Cannabinoid Res; 2021 Dec; 6(6):564-572. PubMed ID: 33998902
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products.
    Gibson LP; Mueller RL; Winiger EA; Klawitter J; Sempio C; Williams S; Bryan AD; Bidwell LC; Hutchison KE
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):320-334. PubMed ID: 36378267
    [No Abstract]   [Full Text] [Related]  

  • 4. Can we predict the treatment doses of THC and CBD and does it matter?
    Halamish N; Schleider LB; McGuire S; Novack V
    Eur J Intern Med; 2023 Jun; 112():100-108. PubMed ID: 37003923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic.
    Rapin L; Gamaoun R; El Hage C; Arboleda MF; Prosk E
    J Cannabis Res; 2021 Jun; 3(1):19. PubMed ID: 34162446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends.
    Lyu X; Illamola SM; Marino SE; Leppik IE; Dahmer S; Lehfeldt P; Conway JM; Remmel RP; Kingsley K; Birnbaum AK
    Curr Ther Res Clin Exp; 2023; 99():100709. PubMed ID: 37538850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center.
    Raghunathan NJ; Brens J; Vemuri S; Li QS; Mao JJ; Korenstein D
    Support Care Cancer; 2022 Sep; 30(9):7491-7497. PubMed ID: 35665859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries.
    Tanco K; Olson A; Fellman B; Jankowski M; Lai SY; Shete S; Harbison K; Scheid J; Bruera E
    J Palliat Med; 2023 Nov; 26(11):1482-1487. PubMed ID: 37285183
    [No Abstract]   [Full Text] [Related]  

  • 9. Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland.
    Zürcher K; Dupont C; Weber P; Grunt S; Wilhelm I; Eigenmann DE; Reichmuth ML; Fankhauser M; Egger M; Fenner L
    Eur J Pediatr; 2022 Jan; 181(1):335-347. PubMed ID: 34309706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental
    Bidwell LC; Martin-Willett R; Skrzynski C; Lisano J; Ortiz Torres M; Giordano G; Hutchison KE; Bryan AD
    Cannabis Cannabinoid Res; 2024 Jan; ():. PubMed ID: 38252547
    [No Abstract]   [Full Text] [Related]  

  • 11. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot.
    Pennypacker SD; Cunnane K; Cash MC; Romero-Sandoval EA
    Front Pharmacol; 2022; 13():921493. PubMed ID: 35734402
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.
    Kayser RR; Haney M; Raskin M; Arout C; Simpson HB
    Depress Anxiety; 2020 Aug; 37(8):801-811. PubMed ID: 32383271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.
    Kruger DJ; Kruger JS
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabis-Based Products for Chronic Pain : A Systematic Review.
    McDonagh MS; Morasco BJ; Wagner J; Ahmed AY; Fu R; Kansagara D; Chou R
    Ann Intern Med; 2022 Aug; 175(8):1143-1153. PubMed ID: 35667066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsy.
    Gherzi M; Milano G; Fucile C; Calevo MG; Mancardi MM; Nobili L; Astuni P; Marini V; Barco S; Cangemi G; Manfredini L; Mattioli F; De Grandis E
    Complement Ther Med; 2020 Jun; 51():102402. PubMed ID: 32507423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
    McFadden BR; Malone T
    Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.